Page 4 - Managed Care News Today

A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.

On Wednesday, April 24, at 6 p.m. at the Dietrich Theater in downtown Tunkhannock, John Alunni, Administrator at Wyoming County Human Services, and Cammie Anderson, BA Certified Prevention Specialist Drug

Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.

The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.

At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.

Negotiations between a group representing senior care organizations and the insurers tasked with overseeing the state’s summer transition of long-term care services collapsed earlier this month after the two sides couldn’t come to an agreement — but the impact is still unclear for older Hoosiers. The state insists it’s on track to launch its Medicaid […] The post Senior care organization group pulls out of managed care, leaving future uncertain appeared first o...

The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.

CMS published two final rules on April 22 designed to expand access in the Medicaid fee-for-service and managed care programs. 

Biden-Harris Administration Takes Action to Increase Access to Care

The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting included multiple poster presentations featuring studies on atopic dermatitis, 2 of which focused on the impact of ruxolitinib cream monotherapy and educating managed care professionals.